key: cord-1016707-sca1svne
authors: Gautret, Philippe; Hoang, Van Thuan; Chaudet, Hervé; Lagier, Jean-Christophe; Raoult, Didier
title: Response to uncertain effect of hydroxychloroquine and azithromycin on SARS-CoV-2 viral load.
date: 2021-01-04
journal: Int J Antimicrob Agents
DOI: 10.1016/j.ijantimicag.2020.106244
sha: 64598dd56c35577a3b43a9c46e1d9ce6aa11a62f
doc_id: 1016707
cord_uid: sca1svne

nan

Letter to the Editor Response to uncertain effect of hydroxychloroquine and azithromycin on SARS-CoV-2 viral load. ✩ We agree with colleagues that the method used in our paper [1] is not optimal given the longitudinal study design with each patient being repeatedly measured on multiple occasions. The mixed-effects logistic regression model can be used to model the change within each patient, and hence give an unbiased estimate of treatment effect. For that reason, we reanalyzed our data including all 42 patients initially enrolled in our survey, following the intention-to-treat concept. Using this model, we estimated the correlation between positive results by real-time PCR, taking into account the interaction effects of hydroxychloroquine, azithromycin, age, gender and NEWS severity score [2] at inclusion. Table 1 shows the results of the mixed-effects logistic regression model. Hydroxychloroquine and azithromycin were found to be significantly associated with a decrease in positive PCR results with OR = 0.24, 95%CI = [0.12 -0.49], p = 7.65.10-5 and OR = 0.38, 95%CI [0.17 -0.81], p = 0.0122, respectively. In conclusion, despite the low number of patients included, the reintegration of excluded patients in our analysis, and using the mixed-effects logistic regression model, the results led to confirm the effectiveness of the hydroxychloroquine and azithromycin treatment on viral clearance.

Uncertain effects of hydroxychloroquine and azithromycin on SARS-Cov-2 viral load

Novel coronavirus infection during the 2019-2020 epidemic: preparing intensive care units-the experience in Sichuan Province, China

Didier Raoult * IHU-Méditerranée Infection

The authors declare no competing interests.

Not applicable